• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

移植中混合嵌合体定量的新方法。

New methods for the quantification of mixed chimerism in transplantation.

机构信息

Immunogenetic Laboratory, EFS PACC, Marseille, France.

CNRS, EFS, ADES, Aix Marseille Université, Marseille, France.

出版信息

Front Immunol. 2023 Jan 19;14:1023116. doi: 10.3389/fimmu.2023.1023116. eCollection 2023.

DOI:10.3389/fimmu.2023.1023116
PMID:36742303
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9892455/
Abstract

BACKGROUND

Quantification of chimerism showing the proportion of the donor in a recipient is essential for the follow-up of hematopoietic stem cell transplantation but can also be useful to document an immune tolerance situation after solid organ transplantation. Historically, chimerism has been quantified from genomic DNA, but with technological advances, chimerism from donor-derived cell-free DNA seems particularly relevant in solid organ transplantation.

METHODS

The reference method was until recently the short tandem repeat technique, but new innovative techniques as digital PCR (dPCR) and NGS, have revolutionized the quantification of chimerism, such as the so-called microchimerism analysis. After a short review of chimerism methods, a comparison of chimerism quantification data for two new digital PCR systems (QIAcuity™ dPCR (Qiagen) and QuantStudio Absolute Q (ThermoFisher) and two NGS-based chimerism quantification methods (AlloSeq HCT™ (CareDx) and NGStrack™ (GenDX)) was performed.

RESULTS

These new methods were correlated and concordant to routinely methods (r²=0.9978 and r²=0.9974 for dPCR methods, r²=0.9978 and r²=0.9988 for NGS methods), and had similar high performance (sensitivity, reproductibility, linearity).

CONCLUSION

Finally, the choice of the innovative method of chimerism within the laboratory does not depend on the analytical performances because they are similar but mainly on the amount of activity and the access to instruments and computer services.

摘要

背景

定量嵌合体显示供体在受体内的比例对于造血干细胞移植的随访至关重要,但也可用于证明实体器官移植后的免疫耐受情况。从历史上看,嵌合体是从基因组 DNA 中定量的,但随着技术的进步,来自供体游离 DNA 的嵌合体在实体器官移植中似乎特别相关。

方法

参考方法直到最近一直是短串联重复技术,但新的创新技术,如数字 PCR(dPCR)和 NGS,已经彻底改变了嵌合体的定量,例如所谓的微嵌合体分析。在简要回顾嵌合体方法后,对两种新的数字 PCR 系统(Qiagen 的 QIAcuity™ dPCR 和 ThermoFisher 的 QuantStudio Absolute Q)和两种基于 NGS 的嵌合体定量方法(CareDx 的 AlloSeq HCT™ 和 GenDX 的 NGStrack™)的嵌合体定量数据进行了比较。

结果

这些新方法与常规方法相关且一致(dPCR 方法的 r²=0.9978 和 r²=0.9974,NGS 方法的 r²=0.9978 和 r²=0.9988),并且具有相似的高性能(灵敏度、重现性、线性)。

结论

最后,实验室中嵌合体创新方法的选择并不取决于分析性能,因为它们相似,但主要取决于活动量以及对仪器和计算机服务的访问。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0a/9892455/76c1b1f30d28/fimmu-14-1023116-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0a/9892455/063125f3d72a/fimmu-14-1023116-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0a/9892455/fa2c5bfc26f3/fimmu-14-1023116-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0a/9892455/bbd1522be831/fimmu-14-1023116-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0a/9892455/09172c2b95dd/fimmu-14-1023116-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0a/9892455/aee8df43275f/fimmu-14-1023116-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0a/9892455/76c1b1f30d28/fimmu-14-1023116-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0a/9892455/063125f3d72a/fimmu-14-1023116-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0a/9892455/fa2c5bfc26f3/fimmu-14-1023116-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0a/9892455/bbd1522be831/fimmu-14-1023116-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0a/9892455/09172c2b95dd/fimmu-14-1023116-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0a/9892455/aee8df43275f/fimmu-14-1023116-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4a0a/9892455/76c1b1f30d28/fimmu-14-1023116-g006.jpg

相似文献

1
New methods for the quantification of mixed chimerism in transplantation.移植中混合嵌合体定量的新方法。
Front Immunol. 2023 Jan 19;14:1023116. doi: 10.3389/fimmu.2023.1023116. eCollection 2023.
2
Early mixed hematopoietic chimerism detection by digital droplet PCR in patients undergoing gender-mismatched hematopoietic stem cell transplantation.通过数字液滴PCR对接受性别不匹配造血干细胞移植的患者进行早期混合造血嵌合体检测。
Clin Chem Lab Med. 2017 Jul 26;55(8):1115-1121. doi: 10.1515/cclm-2016-0900.
3
Evaluation of Next-Generation Sequencing and Crystal Digital PCR for Chimerism Monitoring of Post-Allogeneic Hematopoietic Stem Cell Transplantation.评价二代测序和晶芯数字 PCR 技术在异基因造血干细胞移植后嵌合体监测中的应用。
Transplant Cell Ther. 2021 Jan;27(1):89.e1-89.e10. doi: 10.1016/j.bbmt.2020.09.023. Epub 2020 Sep 24.
4
Chimerism Testing by Next Generation Sequencing for Detection of Engraftment and Early Disease Relapse in Allogeneic Hematopoietic Cell Transplantation and an Overview of NGS Chimerism Studies.基于下一代测序的嵌合率检测在异基因造血细胞移植中用于植入和早期疾病复发的检测,以及对下一代测序嵌合率研究的概述。
Int J Mol Sci. 2023 Jul 23;24(14):11814. doi: 10.3390/ijms241411814.
5
Digital PCR to assess hematopoietic chimerism after allogeneic stem cell transplantation.采用数字PCR评估异基因干细胞移植后的造血嵌合状态。
Exp Hematol. 2015 Jun;43(6):462-8.e1. doi: 10.1016/j.exphem.2015.02.006. Epub 2015 Mar 18.
6
One fits all: a highly sensitive combined ddPCR/pyrosequencing system for the quantification of microchimerism after hematopoietic and solid organ transplantation.一种适用于所有情况的高度敏感的联合 ddPCR/焦磷酸测序系统,用于造血和实体器官移植后的微嵌合体定量。
Clin Chem Lab Med. 2023 May 11;61(11):1994-2001. doi: 10.1515/cclm-2023-0198. Print 2023 Oct 26.
7
Ultra-Sensitive Droplet Digital PCR for the Assessment of Microchimerism in Cellular Therapies.超敏液滴数字 PCR 用于细胞治疗中微嵌合体的评估。
Biol Blood Marrow Transplant. 2018 May;24(5):1069-1078. doi: 10.1016/j.bbmt.2017.12.802. Epub 2018 Jan 2.
8
Engraftment and Measurable Residual Disease Monitoring after Hematopoietic Stem Cell Transplantation: Comparison of Two Chimerism Test Strategies, Next-Generation Sequencing versus a Combination of Short-Tandem Repeats and Quantitative PCR.造血干细胞移植后嵌合体和可测量残留疾病监测:二代测序与短串联重复序列和定量 PCR 联合检测策略的比较。
J Mol Diagn. 2024 Apr;26(4):233-244. doi: 10.1016/j.jmoldx.2024.01.007. Epub 2024 Feb 1.
9
Rapid single nucleotide polymorphism based method for hematopoietic chimerism analysis and monitoring using high-speed droplet allele-specific PCR and allele-specific quantitative PCR.基于快速单核苷酸多态性的方法,利用高速液滴等位基因特异性 PCR 和等位基因特异性定量 PCR 进行造血嵌合体分析和监测。
Clin Chim Acta. 2015 May 20;445:101-6. doi: 10.1016/j.cca.2015.03.018. Epub 2015 Mar 20.
10
Validation of next-generation sequencing-based chimerism testing for accurate detection and monitoring of engraftment in hematopoietic stem cell transplantation.基于新一代测序的嵌合体检测在造血干细胞移植中准确检测和监测植入情况的验证
Front Genet. 2023 Oct 23;14:1282947. doi: 10.3389/fgene.2023.1282947. eCollection 2023.

引用本文的文献

1
Discovery and comprehensive analysis of a congenital chimerism via paternity testing using short tandem repeat genotyping.通过短串联重复序列基因分型进行亲子鉴定发现并全面分析先天性嵌合体
Int J Legal Med. 2025 Sep;139(5):2117-2124. doi: 10.1007/s00414-025-03501-6. Epub 2025 May 8.
2
cfDNA Chimerism and Somatic Mutation Testing in Early Prediction of Relapse After Allogeneic Stem Cell Transplantation for Myeloid Malignancies.cfDNA嵌合与体细胞突变检测在髓系恶性肿瘤异基因干细胞移植后复发早期预测中的应用
Cancers (Basel). 2025 Feb 13;17(4):625. doi: 10.3390/cancers17040625.
3
Combined Solid Organ Transplant and Transfusion-Associated Graft-Versus-Host Disease in a Lung Transplant Recipient: An Uncertain Culprit With Lethal Complications.

本文引用的文献

1
Streamlined and quantitative detection of chimerism using digital PCR.采用数字 PCR 进行简化和定量的嵌合体检测。
Sci Rep. 2022 Jun 17;12(1):10223. doi: 10.1038/s41598-022-14467-5.
2
Chimerism monitoring using biallelic single nucleotide or insertion/deletion polymorphisms: How many markers to screen?利用双等位基因单核苷酸或插入/缺失多态性进行嵌合体监测:需要筛选多少个标记?
Clin Chim Acta. 2022 Jul 1;532:123-129. doi: 10.1016/j.cca.2022.05.026. Epub 2022 Jun 3.
3
Current commercial dPCR platforms: technology and market review.当前商业数字 PCR 平台:技术与市场综述。
肺移植受者中实体器官联合移植与输血相关移植物抗宿主病:一个伴有致命并发症的不明病因
Case Rep Transplant. 2024 Dec 21;2024:3034200. doi: 10.1155/crit/3034200. eCollection 2024.
4
Donor-derived cell-free DNA-based liquid biopsies to determine future kidney transplant rejection.基于供体游离DNA的液体活检用于确定未来肾移植排斥反应。
Kidney Res Clin Pract. 2025 Sep;44(5):705-725. doi: 10.23876/j.krcp.23.286. Epub 2024 Sep 13.
5
Technical Advances in Circulating Cell-Free DNA Detection and Analysis for Personalized Medicine in Patients' Care.循环游离DNA检测与分析技术进展在患者护理个性化医疗中的应用
Biomolecules. 2024 Apr 19;14(4):498. doi: 10.3390/biom14040498.
6
Utility of Next-Generation Sequencing-Based Chimerism Analysis for Early Relapse Prediction following Allogenic Hematopoietic Cell Transplantation.基于下一代测序的嵌合体分析在异基因造血细胞移植后早期复发预测中的应用。
Int J Mol Sci. 2024 Feb 28;25(5):2811. doi: 10.3390/ijms25052811.
7
Seventy-five years of service: an overview of the College of American Pathologists' proficiency testing program in histocompatibility and identity testing.七十五年的服务历程:美国病理学家学会组织相容性与身份鉴定能力验证计划综述
Front Genet. 2023 Dec 19;14:1331169. doi: 10.3389/fgene.2023.1331169. eCollection 2023.
8
Chimerism Testing by Next Generation Sequencing for Detection of Engraftment and Early Disease Relapse in Allogeneic Hematopoietic Cell Transplantation and an Overview of NGS Chimerism Studies.基于下一代测序的嵌合率检测在异基因造血细胞移植中用于植入和早期疾病复发的检测,以及对下一代测序嵌合率研究的概述。
Int J Mol Sci. 2023 Jul 23;24(14):11814. doi: 10.3390/ijms241411814.
Crit Rev Biotechnol. 2023 May;43(3):433-464. doi: 10.1080/07388551.2022.2037503. Epub 2022 Mar 15.
4
Chimerism analysis for clinicians: a review of the literature and worldwide practices.临床医师的嵌合体分析:文献综述及全球实践
Bone Marrow Transplant. 2022 Mar;57(3):347-359. doi: 10.1038/s41409-022-01579-9. Epub 2022 Jan 26.
5
Cell-free DNA diagnostics in transplantation utilizing next generation sequencing.利用下一代测序技术进行移植中的游离DNA诊断
Hum Immunol. 2021 Nov;82(11):850-858. doi: 10.1016/j.humimm.2021.07.006. Epub 2021 Sep 30.
6
A practical guide to chimerism analysis: Review of the literature and testing practices worldwide.嵌合体分析实用指南:文献回顾与全球检测实践。
Hum Immunol. 2021 Nov;82(11):838-849. doi: 10.1016/j.humimm.2021.07.013. Epub 2021 Aug 14.
7
dPCR application in liquid biopsies: divide and conquer.液活检中的数字 PCR 应用:分而治之。
Expert Rev Mol Diagn. 2021 Jan;21(1):3-15. doi: 10.1080/14737159.2021.1860759. Epub 2020 Dec 30.
8
Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms.通过下一代测序评估外周血中的微小残留病作为髓系肿瘤个性化移植监测的补充工具
J Clin Med. 2020 Nov 25;9(12):3818. doi: 10.3390/jcm9123818.
9
Evaluation of Next-Generation Sequencing and Crystal Digital PCR for Chimerism Monitoring of Post-Allogeneic Hematopoietic Stem Cell Transplantation.评价二代测序和晶芯数字 PCR 技术在异基因造血干细胞移植后嵌合体监测中的应用。
Transplant Cell Ther. 2021 Jan;27(1):89.e1-89.e10. doi: 10.1016/j.bbmt.2020.09.023. Epub 2020 Sep 24.
10
Beyond chimerism analysis: methods for tracking a new generation of cell-based medicines.超越嵌合体分析:追踪新一代细胞疗法药物的方法
Bone Marrow Transplant. 2020 Jul;55(7):1229-1239. doi: 10.1038/s41409-020-0822-8. Epub 2020 Feb 5.